|1.||Cazes, Aurélie: 1 article (12/2012)|
|2.||Planquette, Benjamin: 1 article (12/2012)|
|3.||Mourin, Giséle: 1 article (12/2012)|
|4.||Badia, Alain: 1 article (12/2012)|
|5.||Ueda, Junji: 1 article (01/2012)|
|6.||Mamada, Yasuhiro: 1 article (01/2012)|
|7.||Taniai, Nobuhiko: 1 article (01/2012)|
|8.||Hirakata, Atsushi: 1 article (01/2012)|
|9.||Shimizu, Tetsuya: 1 article (01/2012)|
|10.||Uchida, Eiji: 1 article (01/2012)|
09/01/1997 - "Acute gastric bleeding appeared in a patient after the embolization of the right gastric artery with bucrylate during the first session performed to avoid drug reflux into gastric wall arteries. "
02/20/1986 - "These findings suggest a specific sequence of events in the interaction between bucrylate and mural components within the malformations and may explain some important complications of embolization therapy (e.g., delayed hemorrhage after embolization)."
01/01/1986 - "In these cases the bleeding was successfully arrested by intravascular injection of Bucrylate."
10/01/1978 - "Transcatheter vascular occlusion therapy with isobutyl 2-cyanoacrylate (bucrylate) for control of massive upper-gastrointestinal bleeding."
01/01/1977 - "Ultimately the bleeding was brought under control by the use of isobutyl-cyanoacrylate. "
|2.||Arteriovenous Malformations (Arteriovenous Malformation)
01/01/1986 - "Improved technique of bucrylate embolisation in brain arteriovenous malformation. "
01/01/1990 - "Revascularization of brain arteriovenous malformations after embolization with bucrylate."
01/01/1990 - "The experience with embolization of intracerebral arteriovenous malformations (AVMs) with bucrylate (isobutyl-2-cyanoacrylate) in 29 patients is reported. "
09/01/1986 - "Bucrylate offers a number of advantages over other agents previously used to embolize uterine arteriovenous malformations."
02/20/1986 - "Bucrylate was present within arteriovenous malformations as late as 16 months after embolization, although the amount appeared to be diminished. "
|3.||Esophageal and Gastric Varices (Esophageal Varices)
07/01/2000 - "In this study we report on our experience with the use of Bucrylate (Hystoacryl) for the treatment of gastric varices over a period of more than a decade. "
03/01/1987 - "[Endoscopic obliteration of esophageal varices with Bucrylate: an interesting technic, but with too many disadvantages]."
01/01/1978 - "One or more veins feeding esophageal varices were occluded with bucrylate. "
01/01/1978 - "Isobutyl 2-cyanoacrylate (bucrylate) in obliteration of gastric coronary vein and esophageal varices."
07/01/2000 - "Any associated nonbleeding esophageal varices were subjected to traditional sclerotherapy in combination with the Bucrylate treatment. "
02/01/1994 - "Both cases were satisfactorily resolved by super-selective embolization of the fistula with bucrylate. "
01/01/1983 - "Occlusion of a hepatic artery to portal vein fistula with bucrylate."
05/01/1981 - "The patient's symptoms worsened following an attempted to close the fistula with a microcatheter balloon and isobutyl-cyanoacrylate embolization. "
01/01/1981 - "Intravascular use of isobutyl 2-cyanoacrylate: Part 2 Treatment of carotid-cavernous fistulas."
08/01/2000 - "Visceral fistula as a complication of endoscopic treatment of esophageal and gastric varices using isobutyl-2-cyanoacrylate: report of two cases."
08/01/1986 - "Necrosis causes diffusion of Bucrylate through the esophageal wall, and later, secondary fibrosis whereas the product is progressively eliminated into the esophageal lumen."
08/01/1986 - "Bucrylate seems to have a dual action on esophageal varices: immediate obliteration and acute necrosis of the vascular endothelium. "
12/01/1988 - "In this technique, ethanol is injected into the gallbladder and bucrylate is injected into the cystic duct to produce necrosis of the gallbladder."
08/01/1985 - "Ethibloc or Bucrylate can be employed to shut off an organ and to achieve partial organ necrosis. "
|1.||Tissue Adhesives (Tissue Adhesive)
|5.||Acetic Acid (Vinegar)
|7.||Sodium Tetradecyl Sulfate (Sotradecol)